About Ardea Biosciences (NASDAQ:RDEA)
Ardea Biosciences, Inc. (Ardea) is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases. The Company's product portfolio includes Lesinurad (RDEA594), RDEA3170 and BAY 86-9766 (RDEA119). Lesinurad (RDEA594) is an inhibitor of the URAT1 kidney transporter for the treatment of gout. RDEA3170 is a URAT1 kidney transporter inhibitors for the treatment of gout. BAY 86-9766 (RDEA119) is a MEK inhibitor for the treatment of cancer. On June 19, 2012, AstraZeneca PLC acquired the Company.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
Ardea Biosciences (NASDAQ:RDEA) Frequently Asked Questions
What is Ardea Biosciences' stock symbol?
Ardea Biosciences trades on the NASDAQ under the ticker symbol "RDEA."
Has Ardea Biosciences been receiving favorable news coverage?
Headlines about RDEA stock have been trending somewhat positive recently, according to Accern Sentiment. The research group scores the sentiment of press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Ardea Biosciences earned a daily sentiment score of 0.10 on Accern's scale. They also gave media headlines about the biotechnology company an impact score of 44.95 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near future.
How do I buy shares of Ardea Biosciences?
Shares of RDEA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Ardea Biosciences?
Ardea Biosciences' mailing address is 4939 Directors Pl, SAN DIEGO, CA 92121-3829, United States. The biotechnology company can be reached via phone at +1-858-6526500.
MarketBeat Community Rating for Ardea Biosciences (RDEA)MarketBeat's community ratings are surveys of what our community members think about Ardea Biosciences and other stocks. Vote "Outperform" if you believe RDEA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RDEA will underperform the S&P 500 over the long term. You may vote once every thirty days.
Ardea Biosciences (NASDAQ:RDEA) Analyst Ratings History
(Data available from 4/25/2016 forward)
|Date||Brokerage||Action||Rating||Price Target||Impact on Share Price||Details|
Ardea Biosciences (NASDAQ:RDEA) Earnings History and Estimates Chart
Ardea Biosciences (NASDAQ RDEA) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Ardea Biosciences (NASDAQ:RDEA) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Ardea Biosciences (NASDAQ RDEA) Insider Trading and Institutional Ownership History
Ardea Biosciences (NASDAQ RDEA) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
Ardea Biosciences (NASDAQ RDEA) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Ardea Biosciences (NASDAQ:RDEA) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Ardea Biosciences (NASDAQ:RDEA) Income Statement, Balance Sheet and Cash Flow Statement
Ardea Biosciences (NASDAQ RDEA) Stock Chart for Wednesday, April, 25, 2018